Fintel reports that on January 22, 2025, Stifel initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Hold ...

Fintel reports that on January 22, 2025, Stifel initiated coverage of Cytokinetics (NasdaqGS:CYTK) with a Buy recommendation.

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Investment analysts at Stifel Canada issued their FY2024 earnings estimates for TELUS International (Cda) in a research note issued on Wednesday, January 15th. Stifel Canada analyst S. Sukumar ...

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.

Investment dealer Eight Capital has announced plans to wind down its operations, marking a significant shift in Canada’s ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Investing.com -- Stifel analysts highlighted their top small and mid-cap UK stock picks for 2025, focusing on sectors such as industrials, healthcare, and technology.